Canadian Natural to buy Advantage in $2.53 billion deal
Canadian Natural Resources (NYSE:CNQ) signed a definitive agreement to acquire Advantage Energy in a transaction valued at approximately $2.53 billion, adding around 79,000 BOE/d of production.
Canadian Natural Resources (NYSE:CNQ) signed a definitive agreement to acquire Advantage Energy in a transaction valued at approximately $2.53 billion, adding around 79,000 BOE/d of production.
Cytokinetics (NASDAQ:CYTK) received FDA approval to update MYQORZO's prescribing information with Phase 3 MAPLE-HCM results comparing the treatment with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
Niu Technologies (NASDAQ:NIU) reported third-quarter 2026 revenue of RMB1,713.6 million, up 1.2% year over year, but recorded a RMB34 million net loss.
iQIYI (NASDAQ:IQ) reported third-quarter 2026 revenue of RMB6.01 billion, down 10% year over year, as its net loss narrowed and operating cash flow returned to positive territory.
Baidu (NASDAQ:BIDU) reported third-quarter 2026 net income of RMB1.4 billion, reversing a RMB11.2 billion loss from the same period last year, as revenue reached RMB30.8 billion.
Aclaris Therapeutics (NASDAQ:ACRS) has initiated its Phase 2b ALPHA trial of modzatinib in moderate-to-severe lichen planus, beginning with the oral erosive disease cohort.
Aclaris Therapeutics (NASDAQ:ACRS) reported that its Phase 2 ADMIRATION trial of bosakitug failed to meet its primary and secondary endpoints in patients with moderate-to-severe atopic dermatitis.
Brent crude and West Texas Intermediate crude fell as traders weighed forecasts of a fourth-quarter oil surplus against continuing shipping risks in the Strait of Hormuz.
Alpha Tau Medical (NASDAQ:DRTS) reported objective tumor responses in all six evaluable patients with recurrent glioblastoma in its REGAIN trial, while all eight treated patients remained alive as of November 11, 2026.
Israel Police arrested five suspects over an alleged NIS 16 million cryptocurrency scheme, according to a report by The Jerusalem Post.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade
